Week31, 2024
1. Influenza activity remains low nationally, with only 0.6% of respiratory specimens testing positive for influenza in clinical labs.
2. Of the 172 clinical lab specimens testing positive, 84.3% were Influenza A and 15.7% were Influenza B.
3. Public health labs detected 50 positive specimens; 98% were Influenza A, with subtypes H1N1 (42.2%) and H3N2 (57.8%) co-circulating, and 2% were Influenza B (all Victoria lineage).
4. No influenza-associated pediatric deaths were reported this week, with cumulative deaths for the season at 188.
5. FluSurv-NET reported no influenza-related hospitalizations for Week 31, with a cumulative total of 25,317 this season.
6. Outpatient visits for ILI accounted for 1.5% of healthcare visits, staying below the national baseline.
7. One human infection with Influenza A(H3N2)v was reported, with no severe outcomes or transmission to close contacts.
8. CDC reports ongoing circulation of multiple respiratory viruses, including influenza, SARS-CoV-2, and RSV, potentially impacting ILI trends.
9. Antiviral susceptibility testing shows a small presence of resistant strains, with high resistance to adamantanes observed in Influenza A.
10. Future flu activity remains uncertain due to the interplay of several respiratory viruses and variations in regional influenza patterns.